Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

17.89 +0.30 (+1.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
US Stocks Open Higher; Kimco Realty To Acquire RPT Realty
U.S. stocks traded higher this morning, with the Dow Jones gaining over 250 points on Monday. Following the market opening Monday, the Dow traded up 0.81% to 34,626.22 while the NASDAQ rose 0.61% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
The company tested a regimen of chemotherapy and its tumor-treating fields. 
Via Investor's Business Daily
Is NovoCure Stock a Buy Now?
There's nobody else angling for its market share, but that might not be enough. 
Via The Motley Fool
Why Novocure Was a Healthy Stock Today
The company stands to win big if its cancer-fighting technology does well in a late-stage clinical trial. 
Via The Motley Fool
What 9 Analyst Ratings Have To Say About NovoCure
Via Benzinga
NovoCure (NVCR) Q2 2023 Earnings Call Transcript
NVCR earnings call for the period ending June 30, 2023. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Could NovoCure Stock Help You Become a Millionaire?
The stock has some significant upside, but it also comes with considerable risks and volatility. 
Via The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy in August
These two innovative growth stocks appear deeply undervalued based on their long-term potential. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
NovoCure Earnings Preview
Via Benzinga
Here's Why Novocure Stock Dropped 42% in June
The healthcare company presented the results of an important clinical trial that has mixed implications for its future cash flows. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 46 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Via Benzinga
Why Novocure Stock Tumbled by Nearly 16% Today
The company posted a notably deeper net loss in its freshly reported quarter, while its revenue fell. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 56 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 59 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 40 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 50 companies reached new 52-week lows. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon
These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials. 
Via InvestorPlace
This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street
A big turnaround could be in the cards for this medical device maker. 
Via The Motley Fool
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
The Nasdaq held near 52-week highs while small caps ramped up. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 29 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.